比如这个生物科技公司$迪卡斯(DCTH)$
相比IPO的时候缩骨了310亿倍
复权回去曾经的一股值5000亿刀
开眼界哈哈
—————
We have a history of reverse splits, which have severely impacted our common stock price.
Since our initi...查看全文
投资者阿登2023-08-16 15:28
迪卡斯(DCTH)盘前暴涨80%,报5.65美元。
美国食品和药物管理局(FDA)批准HEPZATO KIT(melphalan/Hepatic Delivery System)作为肝脏定向治疗,用于成人患者的转移性葡萄膜黑色素瘤,其不可切除的肝脏转移影响不到50%的肝脏,并且没有仅限于可切除或辐射的骨骼、淋巴结、皮下组织或肺的肝外疾病...查看全文
chuminhua2023-08-16 11:30
8/15,在 FDA 批准 Delcath Systems $迪卡斯(DCTH)$ 公司的 Hepzato用于治疗某些已扩散到肝脏的转移性葡萄膜黑色素瘤的成人患者后,该公司的股价上涨了 117% 以上。 该药将化疗药物melphalan与 Delcath 的肝脏输送系统相结合,旨在允许在靶组织中更高的药物暴露量,同时限制全身毒性。
具体来...查看全文
长红通通2023-08-15 22:58
$迪卡斯(DCTH)$ 美股发布当天发布利好当天大涨,A股当天发布利好叫利好出净,提前埋伏的资金大量出货。至于为什么有那么一些未卜先知的神秘资金提前进入利好还没发布的个股,这只能说这是大A的特色咯!查看全文
产业链观察2023-08-15 17:11
#药闻简讯# 2023年8月14日,$迪卡斯(DCTH)$ 今天宣布美国食品和药物管理局(FDA)批准HEPZATO KIT(美法仑/肝脏给药系统)作为肝脏导向疗法,用于治疗肝脏转移影响小于50%且无肝外疾病的不可切除肝转移性葡萄膜黑色素瘤(mUM)成人患者、或肝外病变局限于骨、淋巴结、皮下组织或肺部,可进行切除或...查看全文
$迪卡斯(DCTH)$ 8-K - Current report Filed: 2017-12-29 AccNo: 0001193125-17-382525 Size: 150 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 9.01: Financial Statements and Exhibits 网页链接
$迪卡斯(DCTH)$ 8-K - Current report Filed: 2017-12-19 AccNo: 0001193125-17-373582 Size: 14 KBItem 8.01: Other Events 网页链接
$迪卡斯(DCTH)$ 8-K - Current report Filed: 2017-12-12 AccNo: 0001193125-17-367478 Size: 15 KBItem 8.01: Other Events 网页链接
$迪卡斯(DCTH)$ 8-K - Current report Filed: 2017-12-12 AccNo: 0001193125-17-367478 Size: 15 KBItem 8.01: Other Events 网页链接
$迪卡斯(DCTH)$ 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redee Filed: 2017-12-07 AccNo: 0001354457-17-000251 Size: 3 KB 网页链接
$迪卡斯(DCTH)$ 8-K - Current report Filed: 2017-12-05 AccNo: 0001193125-17-361621 Size: 14 KBItem 8.01: Other Events 网页链接
$迪卡斯(DCTH)$ 8-K - Current report Filed: 2017-11-28 AccNo: 0001193125-17-354027 Size: 14 KBItem 8.01: Other Events 网页链接
$迪卡斯(DCTH)$ 8-K - Current report Filed: 2017-11-20 AccNo: 0001193125-17-347565 Size: 29 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial Statem...
$迪卡斯(DCTH)$ 8-K - Current report Filed: 2017-11-16 AccNo: 0001193125-17-344851 Size: 471 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 9.01: Financial Statements and Exhibits 网页链接
$迪卡斯(DCTH)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-14 AccNo: 0001564590-17-023836 Size: 5 MB 网页链接